Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals granted inducement awards to purchase 250,700 shares of common stock to eight new employees under its 2023 Inducement Plan. The stock options vest over four years, with 25% vesting on the one-year anniversary and the remainder vesting monthly thereafter.
Key figures
- New hires
- 8
- Vesting years
- 4
- Options granted shares
- 250700
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.